The physiology of p16INK4A-mediated G1 proliferative arrest

Cell Biochemistry and Biophysics

Volumn 33, Issue 2, 2000, Pages 189-197

  Shapiro, Geoffrey I ^a   Edwards, Christian D ^a   Rollins, Barrett J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

ARF; Cancer; Cell cycle; INK4A; p16

Indexed keywords

PROTEIN P16INK4A; PROTEIN P53;

ANIMAL; CELL CYCLE; CELL CYCLE G1 PHASE; DNA DAMAGE; GENETICS; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA DAMAGE; G1 PHASE; GENES, P16; HUMANS; NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034570266     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1385/CBB:33:2:189     Document Type: Conference Paper

References (44)

1. Sherr, C. J. (1996) Cancer cell cycles. Science 274, 1672-1677.
2. Paulovich, A. G., Toczyski, D. P. and Hartwell, L. H. (1997) When checkpoints fail. Cell 88, 315-321.
3. Di Leonardo, A., Linke, S. P., Clarkin, K. and Wahl, G. M. (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540-2551.
4. Slebos, R. J., Lee, M. H., Plunkett, B. S., Kessis, T. D., Williams, B. O., Jacks, T., Hedrick, L., Kastan, M. B. and Cho, K. R. (1994) p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 91, 5320-5324.
5. Waldman, T., Kinzler, K. W. and Vogelstein, B. (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187-5190.
6. Shapiro, G. I., Edwards, C. D., Ewen, M. E. and Rollins, B. J. (1998) p16INK4A participates in a G1 arrest checkpoint in response to DNA damage. Mol. Cell. Biol. 18, 378-387.
7. Morgan, D. O. (1995) Principles of CDK regulation. Nature 374, 131-134.
8. Carnero, A. and Hannon, G. J. (1998) The INK4 family of CDK inhibitors. Curr. Topics Microbiol. Immunol. 227, 43-55.
9. Xiong, Y., Zhang, H. and Beach, D. (1993) Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7, 1572-1583.
10. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G. and Bartek, J. (1995) Retinoblastoma-protein-dependent cell cycle inhibition by the tumor suppressor p16. Nature 375, 503-506.
11. INK4/MTS1 tumor suppressor gene product. EMBO J. 14, 503-511.
12. Serrano, M., Hannon, G. J. and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
13. Russo, A. A., Tong, L., Lee, J. O., Jeffrey, P. D. and Pavletich, N. P. (1998) Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395, 237-243.
14. ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. 92, 6289-6293.
15. INK4 inactivation in non-small cell lung cancer cell lines. Cancer Res. 55, 6200-6209.
16. Koh, J., Enders, G. H., Dynlacht, B. D. and Harlow, E. (1995) Tumor-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375, 506-510.
17. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stocjert, E., Day, R. S. I., Johnson, B. E. and Skolnick, M. H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440.
18. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K. and Carson, D. A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753-756.
19. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9, 3375-3378.
20. INK4 expression in primary lung cancers and cell lines. Cancer Res. 55, 505-509.
21. Hirama, T. and Koeffler, H. P. (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86, 841-854.
22. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A., Ally, D. S., Sheahan, M. D., Clark, W. J., Tucker, M. A., and Dracopoli, N. C. (1994) Germline p16 mutations in familial melanoma. Nature Gene. 8, 15-21.
23. INK4 mutations. N. Engl. J. Med. 333, 970-974.
24. Whelan, A. J., Bartsch, D. and Goodfellow, P. J. (1995) Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N. Engl. J. Med. 333, 975-977.
25. Serrano, M., Lee, H. W., Chin, L., Cordon-Cardo, C., Beach, D. and DePinho, R. A. (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37.
26. Gazzeri, S., Gouyer, V., Vour'ch, C., Brambilla, C. and Brambilla, E. (1998) Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene 16, 497-504.
27. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B. and Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 7, 686-692.
28. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P., Davidson, N. E., Sidransky, D. and Baylin, S. B. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55, 4525-4530.
29. INK4A transcript. Cancer Res. 55, 2995-2997.
30. Stone, S. S., Jiang, P., Dyananth, P., Tavtigian, S. V., Katcher, H., Parry, D., Peters, G. and Kamb, A. (1995) Complex structure and regulation of the P16 (MTS1) locus. Cancer Res. 55, 2988-2994.
31. Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F. and Sherr, C. J. (1998) Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA 95, 8292-8297.
32. Zhang, Y., Xiong, Y. and Yarbrough, W. G. (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725-734.
33. Pomerantz, J., Schreiber-Agus, N., Liegeois, N. J., et al. (1998) The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2′s inhibition of p53. Cell 92, 713-723.
34. Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L. and Vousden, K. H. (1998) p14ARF links the tumour suppressors RB and p53. Nature 395, 124-125.
35. Ink4. Cancer Res. 54, 5816-5820.
36. Hannon, G. J., Demetrick, D. and Beach, D. (1993) Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7, 2378-2391.
37. Hirai, H., Roussel, M. F., Kato, J., Ashmun, R. A. and Sherr, C. J. (1995) Novel INK4 proteins, p18 and p19, are specific inhibitors of cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15, 2672-2681.
38. INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol. Cell. Biol. 17, 2458-2467.
39. INK4B1. Cancer Res. 56, 722-727.
40. Sedlacek, H. H., Czech, J., Naik, R., Kaur, G., et al. (1996) Flavopiridol (L868275; NSC 649890), a new kinase inhibitor for tumor therapy. Int. J. Oncol. 9, 1143-1168.
41. Brusselbach, S., Nettelbeck, D. M., Sedlacek, H. H. and Muller, R. (1998) Cell cycle-independent induction of apoptosis by the anti-tumor drug Flavopiridol in endothelial cells. Int. J. Cancer 77, 146-152.
42. Shimizu, T., Cao, C. X., Shao, R. G. and Pommier, Y. (1998) Lamin B phosphorylation by protein kinase calpha and proteolysis during apoptosis in human leukemia HL60 cells. J. Biol. Chem. 273, 8669-8674.
43. Parker, B. W., Kaur, G., Nieves-Neira, W., (1998) Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol. Blood 91, 458-465.
44. Konig, A., Schwartz, G. K., Mohammad, R. M., Al-Katib, A. and Gabrilove, J. L. (1997) The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines. Blood 90, 4307-4312.